Found 171 results
Filters: Author is Muyldermans, Serge  [Clear All Filters]
Flajnik, M. F., N. Deschacht, and S. Muyldermans, "A case of convergence: why did a simple alternative to canonical antibodies arise in sharks and camels?", PLoS Biol, vol. 9, issue 8, pp. e1001120, 2011 Aug.
Gainkam, L. Olive Tcho, M. Keyaerts, V. Caveliers, N. Devoogdt, C. Vanhove, L. Van Grunsven, S. Muyldermans, and T. Lahoutte, "Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy.", Mol Imaging Biol, vol. 13, issue 5, pp. 940-8, 2011 Oct.
Ben Abderrazek, R., C. Vincke, I. Hmila, D. Saerens, N. Abidi, M. El Ayeb, S. Muyldermans, and B. Bouhaouala-Zahar, "Development of Cys38 knock-out and humanized version of NbAahII10 nanobody with improved neutralization of AahII scorpion toxin.", Protein Eng Des Sel, vol. 24, issue 9, pp. 727-35, 2011 Sep.
Abbady, A. Q., A. Al-Mariri, M. Zarkawi, A. Al-Assad, and S. Muyldermans, "Evaluation of a nanobody phage display library constructed from a Brucella-immunised camel.", Vet Immunol Immunopathol, vol. 142, issue 1-2, pp. 49-56, 2011 Jul 15.
Hassanzadeh-Ghassabeh, G., D. Saerens, and S. Muyldermans, "Generation of anti-infectome/anti-proteome nanobodies.", Methods Mol Biol, vol. 790, pp. 239-59, 2011.
Stijlemans, B., G. Caljon, S. Kumar A. Natesan, D. Saerens, K. Conrath, D. Pérez-Morga, J. N. Skepper, A. Nikolaou, L. Brys, E. Pays, et al., "High affinity nanobodies against the Trypanosome brucei VSG are potent trypanolytic agents that block endocytosis.", PLoS Pathog, vol. 7, issue 6, pp. e1002072, 2011 Jun.
Bouhaouala-Zahar, B., R. Ben Abderrazek, I. Hmila, N. Abidi, S. Muyldermans, and M. El Ayeb, "Immunological aspects of scorpion toxins: current status and perspectives.", Inflamm Allergy Drug Targets, vol. 10, issue 5, pp. 358-68, 2011 Oct.
Gainkam, L. Olive Tcho, V. Caveliers, N. Devoogdt, C. Vanhove, C. Xavier, O. Boerman, S. Muyldermans, A. Bossuyt, and T. Lahoutte, "Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice.", Contrast Media Mol Imaging, vol. 6, issue 2, pp. 85-92, 2011 Mar-Apr.
Vaneycken, I., N. Devoogdt, N. Van Gassen, C. Vincke, C. Xavier, U. Wernery, S. Muyldermans, T. Lahoutte, and V. Caveliers, "Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer.", FASEB J, vol. 25, issue 7, pp. 2433-46, 2011 Jul.
Fernández, L. Ángel, and S. Muyldermans, "Recent developments in engineering and delivery of protein and antibody therapeutics.", Curr Opin Biotechnol, vol. 22, issue 6, pp. 839-42, 2011 Dec.
Thys, B., D. Saerens, L. Schotte, G. De Bleeser, S. Muyldermans, G. Hassanzadeh-Ghassabeh, and B. Rombaut, "A simple quantitative affinity capturing assay of poliovirus antigens and subviral particles by single-domain antibodies using magnetic beads.", J Virol Methods, vol. 173, issue 2, pp. 300-5, 2011 May.
Van de Broek, B., N. Devoogdt, A. D'Hollander, H-L. Gijs, K. Jans, L. Lagae, S. Muyldermans, G. Maes, and G. Borghs, "Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapy.", ACS Nano, vol. 5, issue 6, pp. 4319-28, 2011 Jun 28.
Hendrickx, M. L. V., A. DE Winter, K. Buelens, G. Compernolle, G. Hassanzadeh-Ghassabeh, S. Muyldermans, A. Gils, and P. J. Declerck, "TAFIa inhibiting nanobodies as profibrinolytic tools and discovery of a new TAFIa conformation.", J Thromb Haemost, vol. 9, issue 11, pp. 2268-77, 2011 Nov.
Hmila, I., D. Saerens, R. Ben Abderrazek, C. Vincke, N. Abidi, Z. Benlasfar, J. Govaert, M. El Ayeb, B. Bouhaouala-Zahar, and S. Muyldermans, "A bispecific nanobody to provide full protection against lethal scorpion envenoming.", FASEB J, vol. 24, issue 9, pp. 3479-89, 2010 Sep.
Blanco-Toribio, A., S. Muyldermans, G. Frankel, and L. Ángel Fernández, "Direct injection of functional single-domain antibodies from E. coli into human cells.", PLoS One, vol. 5, issue 12, pp. e15227, 2010.
Buelens, K., G. Hassanzadeh-Ghassabeh, S. Muyldermans, A. Gils, and P. J. Declerck, "Generation and characterization of inhibitory nanobodies towards thrombin activatable fibrinolysis inhibitor.", J Thromb Haemost, vol. 8, issue 6, pp. 1302-12, 2010 Jun.
Vaneycken, I., J. Govaert, C. Vincke, V. Caveliers, T. Lahoutte, P. De Baetselier, G. Raes, A. Bossuyt, S. Muyldermans, and N. Devoogdt, "In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CT.", J Nucl Med, vol. 51, issue 7, pp. 1099-106, 2010 Jul.
Thys, B., L. Schotte, S. Muyldermans, U. Wernery, G. Hassanzadeh-Ghassabeh, and B. Rombaut, "In vitro antiviral activity of single domain antibody fragments against poliovirus.", Antiviral Res, vol. 87, issue 2, pp. 257-64, 2010 Aug.
Bourbeillon, J., S. Orchard, I. Benhar, C. Borrebaeck, A. de Daruvar, S. Dübel, R. Frank, F. Gibson, D. Gloriam, N. Haslam, et al., "Minimum information about a protein affinity reagent (MIAPAR).", Nat Biotechnol, vol. 28, issue 7, pp. 650-3, 2010 Jul.
Kirchhofer, A., J. Helma, K. Schmidthals, C. Frauer, S. Cui, A. Karcher, M. Pellis, S. Muyldermans, C. S. Casas-Delucchi, C. M Cardoso, et al., "Modulation of protein properties in living cells using nanobodies.", Nat Struct Mol Biol, vol. 17, issue 1, pp. 133-8, 2010 Jan.
De Groeve, K., N. Deschacht, C. De Koninck, V. Caveliers, T. Lahoutte, N. Devoogdt, S. Muyldermans, P. De Baetselier, and G. Raes, "Nanobodies as tools for in vivo imaging of specific immune cell types.", J Nucl Med, vol. 51, issue 5, pp. 782-9, 2010 May.
Huang, L., S. Muyldermans, and D. Saerens, "Nanobodies®: proficient tools in diagnostics.", Expert Rev Mol Diagn, vol. 10, issue 6, pp. 777-85, 2010 Sep.